Discover the emergence of dual-payload ADCs and PDCs, which could mark a significant evolution in targeted therapeutics.

Lonza helps biotech firms accelerate from DNA to IND with tailored strategies that reduce risk and speed complex biologics to ...

Psychiatry is often treated as separate to the rest of medicine. It's time to bring psychiatry into the era of precision medicine.

From plastic-eating plants to AI-guided therapies, iGEM 2025 reveals the innovations defining the future of synthetic biology ...

Since the first biosimilar approval in Europe twenty years ago, biosimilars have provided 6.9 billion patient treatment days and now provide 12% of the total volume of biologic treatments in Europe.